ABVC BioPharma (ABVC)

• Market cap: $49.1M
• 1 day: -1.46%
• 5 days: -8.6%
• 1 month: -1.94%
• 3 months: -30.82%
• 6 months: -42.61%
• Year to date: -7.76%
• 1 year: 266.54%
• 5 years: -93.24%
• 10 years: -93.24%
• Sector: Healthcare
• Industry: Biotechnology

About: ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

Employees: 19